secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vireo Growth Inc. (VREOF)
CIK:        0001771706
Form:       8-K
Filed at:   2026-08-13T11:00:35+00:00
Accession:  0001104659-26-095427
Event type: m_and_a
Sentiment:  positive
Materiality: 0.85
Item codes: 1.01, 2.01, 2.03, 3.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Vireo closes PharmaCann Colorado acquisition (17 stores) and secures $85M BMO credit facility
--------------------------------------------------------------------------------

- Acquired PharmaCann Colorado retail assets for ~$48.7M: 3,004,751 subordinate voting shares plus assumed liabilities; 17 dispensaries added, footprint now 56 in Colorado.
- New $85M asset-based revolving credit facility with Bank of Montreal, expandable to $105M, maturing Aug 7, 2031; SOFR+1.75-2.00% or base+0.75-1.00%.
- Proceeds to refinance existing Chicago Atlantic debt and shareholder notes, fund working capital, capex, and permitted acquisitions.
- 61,728 Consideration Shares held back for 9 months; CEO John Mazarakis is partner of Chicago Atlantic, an affiliate of prior lender.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1771706/000110465926095427/0001104659-26-095427-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1771706/000110465926095427/tm2622759d4_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-095427

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer